E.g., 11/28/2020
E.g., 11/28/2020

bioMérieux receives FDA Clearance for BioFire’s FilmArray® Respiratory Panel 2 (RP2)

01 June, 2017

The FilmArray® RP2 reduces sample-to-result time to only 45 minutes while enhancing pathogen coverage and overall sensitivity

The FilmArray® Respiratory Panel 2 plus (RP2plus) gets CE marked

20 April, 2017

bioMérieux receives FDA 510(k) clearance for its BacT/ALERT® VIRTUO™ fully automated blood culture system

06 April, 2017

bioMérieux’s VIDAS® B•R•A•H•M•S PCT™ becomes the first FDA-cleared procalcitonin assay as an aid for antibiotic stewardship in respiratory infections and sepsis

24 February, 2017

bioMérieux and Banyan Biomarkers Partner to Develop, Validate and Market Blood-Based Biomarkers for Traumatic Brain Injury

19 January, 2017

bioMérieux launches EMAG®, a new generation automated system for the extraction of DNA and RNA

10 November, 2016

FilmArray® Respiratory Panel EZ is CLIA waived by the FDA

11 October, 2016

bioMérieux enlarges its pathogen identification capability on VITEK® MS

06 July, 2016

With a database of more than 15,000 strains VITEK® MS improves clinical decision-making for infectious diseases

bioMerieux Receives FDA Clearance for Expanded Use of VIDAS® B•R•A•H•M•S PCT™ Test for Managing Sepsis Patients with elevated risk of mortality

01 July, 2016

Tracking PCT – a biomarker for bacterial infections – over time provides strong indication of likely mortality, enabling physicians to personalize care for high-risk patients

bioMérieux and Antwerp University unveil the final results of the first Global Point Prevalence Survey of antibiotic use and resistance rates in hospitals

11 April, 2016

Huge discrepancies in antibiotic use practices between countries 2nd line antibiotics2 too frequently prescribed

Pioneering diagnostics